A2ALL: Adult-to-Adult Living Donor Transplant Cohort Study
The study is being conducted for the following reasons:
- To determine the prevalence, course, and predictors of poor Health Related Quality of Life (HRQOL) outcomes associated with living donor donation.
- To collect data and biosamples prior to, during, and after a living donor liver transplant (LDLT) among all donors and recipients for use by other adult-to-adult living donor liver transplant studies and future studies.
- To study the effects of pressure and flow on the outcomes of LDLT.
- To characterize the differences between living donor liver transplant and deceased donor liver transplant in terms of recipient post-transplant outcomes including patient and graft survival, surgical morbidity, and resource utilization.
- To compare the long-term histological outcomes in recipients of LDLT and deceased donor liver transplant (DDLT) with recurrent hepatitis C virus (HCV) infection.
- To understand the history of pain management and to measure quality of care in pain control in living donors following partial hepatectomy.
Trial Website: https://clinicaltrials.gov/show/NCT01619475
Are you Eligible? (Inclusion Criteria)
Inclusion Criteria:
Recipients
- Age 18 or older at the time of consent
- Has had a living donor identified and accepted and LDLT is planned
- Informed consent obtained
- Is listed for single organ (liver) transplantation
Donors
- Age 18 or older at the time of consent
- Has undergone donor evaluation process and was accepted and donation surgery is planned
- Informed consent obtained
Exclusion Criteria:
None
Specialty Area(s)
Liver
Transplant
Trial Location
NYP/Columbia
New York, NY 10032
United States